Comparison of Clinical Outcomes between del Nido Cardioplegia and Microplegia among Patients Undergoing Elective Mitral Valve Replacement

被引:1
|
作者
Hafiz, Erhan [1 ]
Altinbas, Ozgur [2 ]
Kutlu, Isik Betil [1 ]
Moda, Mehmet [1 ]
Celkan, Mehmet Adnan [1 ]
机构
[1] Gaziantep Univ, Dept Cardiovasc Surg, Med Fac, TR-27410 Gaziantep, Turkiye
[2] Gaziantep Univ, Dept Operat Room Serv, Vocat Sch Hlth Serv, TR-27310 Gaziantep, Turkiye
来源
HEART SURGERY FORUM | 2023年 / 26卷 / 06期
关键词
cardioplegia; del Nido; microplegia; mitral valve replacement; ADULT CARDIAC-SURGERY; BLOOD CARDIOPLEGIA; MYOCARDIAL PROTECTION;
D O I
10.59958/hsf.6381
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Cardioplegia solutions are used to protect the myocardium from ischemic injury caused by cardiopulmonary bypass and various types of cardioplegia solutions have been introduced for cardiac surgery. In this study, we aimed to compare the effects of del Nido cardioplegia and microplegia, which were mostly used in our clinic for intraoperative and postoperative processes among patients who underwent elective mitral valve replacement. As a result, the comparison could be performed in a specific patient group without additional valvular or coronary disease, and cardioplegia distribution could be achieved more efficiently. Methods: Between 2018 and 2023, a total of 120 patients who underwent elective mitral valve replacement via sternotomy with del Nido cardioplegia or microplegia were included in the study. Patients were divided into two groups; group 1 (del Nido, n = 64) and group 2 (microplegia, n = 56). Preoperative characteristics, intraoperative and postoperative early clinical data as primary outcomes, and postoperative mortality rates and intensive care costs as secondary outcomes were compared statistically. Results: There were no statistically significant differences in terms of preoperative characteristics between the two groups. Duration of cross clamp differences between group 1 versus group 2 (45 +/- 16 vs. 57 +/- 19 min), cardiopulmonary bypass (56 +/- 17 vs. 65 +/- 21 min), intensive care length of stay (18.04 +/- 7.41 vs. 22.37 +/- 6.86 h), requirement of intraoperative defibrillation (n = 5 vs. n = 13), and intensive care costs were found to be statistically significantly lower in del Nido group. Conclusion: Either del Nido or microplegia solutions can be used safely in mitral valve replacement operations, however, del Nido cardioplegia has some advantages over intraoperative processes, such as lowering the cross clamp and cardiopulmonary bypass time. Furthermore, patients who received del Nido cardioplegia had shorter intensive care stay and required less intraoperative defibrillation compared with the microplegia group. Therefore, less exposure to anesthesia, the prevention of infection due to shortened operation duration, and greater costeffectiveness can be achieved by using del Nido cardioplegia instead of microplegia.
引用
收藏
页码:E826 / E831
页数:6
相关论文
共 50 条
  • [31] Long-Term Outcomes Are Improved in Elderly Patients Undergoing Mitral Valve Repair Compared With Mitral Valve Replacement
    Thourani, Vinod H.
    Guyton, Robert A.
    Puskas, John D.
    Kilgo, Patrick
    Lattouf, Omar M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A404 - A405
  • [32] One-shot cardioplegia for minimally invasive mitral valve repair-a comparison of del Nido and Bretschneider Histidine-Tryptophan-Ketoglutarate solutions
    Gerber, Witold
    Sanetra, Krzysztof
    Drzewiecka-Gerber, Agnieszka
    Jankowska-Sanetra, Justyna
    Kuczera, Malgorzata
    Bialek, Krzysztof
    Buszman, Piotr Pawel
    Bochenek, Andrzej
    PERFUSION-UK, 2023, 38 (04): : 763 - 770
  • [33] Clinical outcomes in 1731 patients undergoing mitral valve surgery for rheumatic valve disease
    Kim, Wan Kee
    Kim, Ho Jin
    Kim, Joon Bum
    Jung, Sung-Ho
    Choo, Suk Jung
    Chung, Cheol Hyun
    Lee, Jae Won
    HEART, 2018, 104 (10) : 841 - 848
  • [34] Impact of concomitant mitral valve surgery on the clinical outcomes of patients with moderate functional mitral regurgitation and HFpEF undergoing aortic valve replacement: a cohort study
    Tiemuerniyazi, Xieraili
    Yang, Ziang
    Nan, Yifeng
    Song, Yangwu
    Zhao, Wei
    Xu, Fei
    Feng, Wei
    JOURNAL OF CARDIOTHORACIC SURGERY, 2023, 18 (01)
  • [35] Impact of concomitant mitral valve surgery on the clinical outcomes of patients with moderate functional mitral regurgitation and HFpEF undergoing aortic valve replacement: a cohort study
    Xieraili Tiemuerniyazi
    Ziang Yang
    Yifeng Nan
    Yangwu Song
    Wei Zhao
    Fei Xu
    Wei Feng
    Journal of Cardiothoracic Surgery, 18
  • [36] Comparison of outcomes between nonagenarian and younger patients undergoing transcatheter aortic valve replacement (TAVR) with the LOTUS valve
    Ramkumar, S.
    Rashid, H.
    Zaman, S.
    McCormick, L.
    Gooley, R.
    Jackson, D.
    Meredith, I. T.
    EUROPEAN HEART JOURNAL, 2016, 37 : 67 - 67
  • [37] Comparison of Clinical and Echocardiographic Outcomes After Surgical Redo Mitral Valve Replacement and Transcatheter Mitral Valve-in-Valve Therapy
    Kamioka, Norihiko
    Babaliaros, Vasilis
    Morse, Michael Andrew
    Frisoli, Tiberio
    Lerakis, Stamatios
    Iturbe, Jose Miguel
    Binongo, Jose
    Corrigan, Frank
    Yousef, Altayyeb
    Gleason, Patrick
    Wells, John A.
    Caughron, Hope
    Dong, Andy
    Rodriguez, Evelio
    Leshnower, Bradley
    O'Neill, William
    Paone, Gaetano
    Eng, Marvin
    Guyton, Robert
    Block, Peter C.
    Greenbaum, Adam
    JACC-CARDIOVASCULAR INTERVENTIONS, 2018, 11 (12) : 1131 - 1138
  • [38] In-hospital outcomes of patients undergoing concomitant aortic and mitral valve replacement in Germany
    Kreibich, Maximilian
    Kaier, Klaus
    von zur Muehlen, Constantin
    Siepe, Matthias
    Zehender, Manfred
    Bode, Christoph
    Beyersdorf, Friedhelm
    Stachon, Peter
    Bothe, Wolfgang
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2022, 34 (03) : 349 - 353
  • [39] Correction: Characteristics and outcomes of patients undergoing transcatheter mitral valve replacement with the Tendyne system
    Nihal Wilde
    Tetsu Tanaka
    Vivian Vij
    Atsushi Sugiura
    Mitsumasa Sudo
    Eva Eicheler
    Miriam Silaschi
    Johanna Vogelhuber
    Farhad Bakhtiary
    Georg Nickenig
    Marcel Weber
    Sebastian Zimmer
    Clinical Research in Cardiology, 2023, 112 : 703 - 703
  • [40] Causes and Clinical Outcomes of Patients with Mitral Regurgitation Who are ineligible for Transcatheter Mitral Valve Replacement
    Niikura, Hiroki
    Goessl, Mario
    Kshettry, Vibhu
    Olson, Sara
    Sun, Benjamin
    Askew, Judah
    Lesser, John
    Bae, Richard
    Harris, Kevin
    Sorajja, Paul
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (13) : B266 - B267